Plasma Beta-Endorphin Concentration and Naloxone Treatment in Primary Apnea of Prematurity

张雪峰,童笑梅,叶鸿瑁
DOI: https://doi.org/10.3760/cma.j.issn.1673-4912.2004.06.012
2004-01-01
Abstract:Objective To explore the causitive role of β-endorphin and curative effects of Naloxone in primary apnea of prematurity(AOP).Methods With the technique of radioimmuoassay,the plasmaβ-endorphin level was measured in premature infants with apnea(n=21),compared with the control group that without apnea(n=30).Twenty one patients with apnea of prematurity(AOP) were randomly divided into two groups:the group treated with naloxone and the other group treated with aminophylline.Plasma samples were taken 1h prior to treatment and 72h post-treatment.Results The β-endorphin levels were significantly higher in infants with apnea than those in control group(P0.05).The β-endorphin levels were significantly decreased after both NX and aminophylline treatment (P0.05).Futhermore,β-endorphin levels were significantly decreased in NX group than the aminophylline group 72 hours after treatment (P0.05).There was no difference in the effectiveness between the naloxone and aminophylline group(P0.05).No adverse effects were found in neonates treated with naloxone.Conclusion β-endorphin plays a role in the pathophysiology of apnea of prematurity,and naloxone has some curative effects.
What problem does this paper attempt to address?